Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2026, C-RAD B has already paid €0.0091 in dividends. The last payout was in May.

Financials

In the last quarter, C-RAD B had revenue of €7.53M and net profit of €926.13K
(EUR) September 2026
YoY
Revenue 7.53M 25.79%
Gross profit 590.96K 70.58%
Net profit 926.13K 20.64%
EBITDA 943.77K 55.98%

Fundamentals

Metric Value
Market capitalization
€71.5M
Number of shares
31.89M
52-week high/low
€3.55 - €1.70
Dividend yield
0.41%
Dividends TTM
€0.0091
Beta
0.72
P/E ratio
17.69
PEG ratio
0.17
P/B ratio
2.25
P/S ratio
1.90

Company profile

C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise Catalyst Tomo, an enhanced positioning solution for tomotherapy; Catalyst PT, a real-time tracking solution for particle therapy; Cyrpa laser positioning products; cAccessory, which automates the registration and validation of treatment accessories; and cPatient that automates patient identity validation without the need for contact between patients and devices. In addition, it offers installation, application training, and aftersales services. C-Rad AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.

Name
C-RAD B
CEO
Tomas Blomquist
Headquarters Uppsala, up
Sweden
Website
IPO
07/23/2007
Employees 98

Ticker symbols

Exchange Symbol
Sto
CRAD-B.ST
Frankfurt
24C.F
Düsseldorf
24C.DU
London
0R44.L
Stockholm
CRAD B.ST
🍪

Parqet  uses cookies. Learn more